虚拟现实疗法针对精神病患者的参考思想:单盲并行组随机对照试验
EunJin Jeon1, Ling Li1,2, Thi-Hung Le1,2
1Department of Psychiatry, Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Psychological medicine
|April 28, 2025
概括
虚拟现实 (VR) 疗法有效地减少了精神病患者的妄想. 这种VR治疗显示了轻微的副作用和改善了社会功能,为管理精神病症状提供了一种有前途的新方法.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 数字治疗学数字治疗学
- 临床心理学 临床心理学
背景情况:
- 有限的研究存在于虚拟现实 (VR) 对于精神病中的迫害妄想.
- 这项研究探讨了VR治疗精神病患者对参考错觉 (DOR) 的疗效和安全性.
研究的目的:
- 评估VR疗法在稳定精神病门诊患者中减少妄想的有效性.
- 评估VR治疗的安全性.
- 通过路径分析探索影响VR治疗结果的心理因素.
主要方法:
- 78名稳定的精神病门诊患者被随机分为VR治疗 (VR-T) 或VR控制 (VR-C) 组.
- 参与者接受了前后评估,使用精神病症状评分尺度-妄想 (PSYRATS-D) 和修订绿色等. 偏执思维量表 (R-GPTS). 偏执思维量表.
- 进行了各种自我评级尺度和安全评估;建立了路径模型.
主要成果:
- 与VR-C组相比,VR-T组的PSYRATS-D得分显著改善.
- 对于社会和职业功能评估量表 (SOFAS) 的得分,观察到一个显著的群体×时间相互作用.
- 虚拟现实疾病发生频繁,但是轻微的;对负面评价的恐惧和抑郁症的得分介于结果.
结论:
- 虚拟现实疗法在年轻,稳定的精神病患者中减少妄想方面表现出有效性.
- 治疗与轻度,耐受性的副作用有关.
- 建议进行进一步的研究,为老年人群开发多样化的VR内容.
相关概念视频
Blinding
3.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.0K
Psychosis: Goals of Pharmacotherapy
713
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
713


